Bionomics Limited is reporting that their experimental drug BNC210, a novel α7 nicotinic acetylcholine receptor modulator, ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

Mongooses and snakes are locked in an evolutionary arms race. Mongooses, with their agility, venom resistance, and protective ...

According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...

Nicotinic receptors are also present on the postsynaptic junctional folds, opposite the sites on the nerve endings from which acetylcholine is released. These nicotinic receptors are composed of ...

An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12 ...

A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients ...

In a report released today, Andrew Tsai from Jefferies maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report), with a ...

Title: Randomized, Double-Blind Study of BNC210, a Negative Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor, in Posttraumatic Stress Disorder (PTSD): The Attune Trial Presenter: Murray ...

A nasal spray therapy may provide postsurgical management of dry eye disease without the need for additional drops or punctal plugs.